IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome.
about
Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.Unraveling the pathophysiology of Sjogren syndrome-associated dry eye diseaseThe osteopontin transgenic mouse is a new model for Sjögren's syndromeReduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transferProgress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update.Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal glandThe important role of T cells and receptor expression in Sjögren's syndrome.Sjögren's syndrome: studying the disease in mice.The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus.Mouse Models of Primary Sjogren's Syndrome.Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition.Current Aspects of Pathogenesis in Sjögren's Syndrome.The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's SyndromeUsefulness of mouse models to study the pathogenesis of Sjögren's syndrome.Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice.T Cell-Associated Cytokines in the Pathogenesis of Sjögren's SyndromeAnimal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome.Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in miceIdentification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy.Sjögren's syndrome: an old tale with a new twistEffects of muscarinic acetylcholine 3 receptor(208-227) peptide immunization on autoimmune response in nonobese diabetic mice.Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.A secretagogue-small interfering RNA conjugate confers resistance to cytotoxicity in a cell model of Sjögren's syndrome.Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and miceDetection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay.Single-cell analysis reveals sexually dimorphic repertoires of Interferon-γ and IL-17A producing T cells in salivary glands of Sjögren's syndrome miceSjögren's syndrome-like disease of C57BL/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus.Anti-IL-7 receptor-α treatment ameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice.Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis.Sjogren's syndrome
P2860
Q33771577-F3016A10-4D18-49AB-AE4E-1E552DF892A1Q33795156-AC6CC1B6-884E-46B8-BCF8-AD1F7EFAA2BCQ33819490-8BC5E0AC-9A6A-47B7-8C39-2D4B769D6B57Q34457345-78614DA1-CB68-459F-A388-0FD0F9C52857Q34473302-E0253F33-6C9C-4FD4-89F0-EB5B76E91897Q34614045-B5FBCF37-1101-47FB-93C0-3E8A2BC2B200Q34720542-5CE0B3D7-4128-4638-81F6-8FC704972D81Q35027540-6E5E2444-202F-4FEC-9AE4-FA9DFE13B11FQ35535169-75C3B871-7315-4DB8-B9A4-1A36F447D818Q35557789-04972C30-6910-4BE7-AAB4-ADF349D24C2BQ35579076-F62FEDEF-254B-4AF8-AC52-D53E29AADE36Q35587450-B69EA311-3D80-41EB-BD84-02825147E59EQ36007430-F184C5F4-0544-40D7-99DC-2D9D9C128A50Q36059424-1963E934-B378-47E6-A5A1-0CEBC5457E1CQ36082974-F677671F-F67C-4720-8144-1632BB99E27EQ36852657-6CBD817F-4384-4CDC-AFD7-5E377D152A43Q36907644-973DFBBA-E5D6-46B2-A05D-1C076756ADDDQ36957148-D77ADDDC-0C9C-4626-8AA8-404E35BCBDF9Q37016308-83778583-E9AC-47B8-84D0-F4F47A0FA112Q37060371-5447519E-BA04-421C-A8D2-CCABE80B0B77Q37129577-B527A473-1092-40CB-AC70-1EEA86C39FC7Q37257149-69BF7386-722C-49CE-A753-D504D3649F6CQ37412285-A5333858-6B33-46C2-A0EA-9F78084701FAQ37733323-FAE31C81-C661-467E-895F-47D8BBB801D3Q38186111-C3120EC7-5811-4CF9-B9EB-23D77173BF7DQ39543676-FD9CC1ED-B15C-408D-86E4-E4B38917A2BCQ39912433-2189EE25-A736-4C01-916B-4FEB27E8CCD4Q40521443-3EEE09CD-9DCE-4956-BBA1-CE76E0A4319CQ41991901-535CAD65-C775-4930-A784-16B9C4DDCE73Q51790192-5A45E6BD-DD17-4E8A-95F1-7AEF78683447Q52572230-74E6B8D8-7227-4FBB-B004-F561AF1ADE16Q54573527-855002B3-19A7-4A15-8D22-4AA926DC9C9FQ55970263-7BA1326F-FC73-4DCB-A611-AFE5D32C45EF
P2860
IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
IL-4-dependent effector phase ...... e model of Sjögren's syndrome.
@en
IL-4-dependent effector phase ...... e model of Sjögren's syndrome.
@nl
type
label
IL-4-dependent effector phase ...... e model of Sjögren's syndrome.
@en
IL-4-dependent effector phase ...... e model of Sjögren's syndrome.
@nl
prefLabel
IL-4-dependent effector phase ...... e model of Sjögren's syndrome.
@en
IL-4-dependent effector phase ...... e model of Sjögren's syndrome.
@nl
P2093
P2860
P1476
IL-4-dependent effector phase ...... e model of Sjögren's syndrome.
@en
P2093
Humphreys-Beher MG
Lindberg A
Martinez J
Nagashima H
Yasunari U
P2860
P304
P356
10.1046/J.1365-3083.2001.00958.X
P577
2001-07-01T00:00:00Z